Related Experiment Video

Updated: Dec 12, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.9K

Dyslipidemia Management in 2020: An Update on Diagnosis and Therapeutic Perspectives

Ioannis D Karantas1, Mehmet E Okur2, Neslihan Ü Okur3

  • 1Nicosia General Hospital, Nicosia, Cyprus.

Endocrine, Metabolic & Immune Disorders Drug Targets
|August 12, 2020
PubMed

Insights

Managing dyslipidemia, a key risk factor for cardiovascular diseases, involves lifestyle changes and medication. Recent evidence guides updated diagnosis, imaging, and treatment strategies for better patient outcomes.

Area of Science:

  • Cardiology and Internal Medicine
  • Pharmacology and Drug Delivery

Background:

  • Cardiovascular diseases (CVDs) are the primary global cause of mortality.
  • Dyslipidemia is a major modifiable risk factor for CVDs.
  • Effective management of dyslipidemia and hypertension is crucial for CVD prevention.

Purpose of the Study:

  • To review the latest evidence on dyslipidemia management.
  • To highlight updated diagnostic tools, including theranostics.
  • To explore future treatment perspectives, focusing on novel drug delivery systems.

Main Methods:

  • Targeted literature review of recent scientific evidence.
  • Analysis of current dyslipidemia management guidelines.
  • Evaluation of novel diagnostic and therapeutic approaches.

Main Results:

  • Updated therapeutic goals for dyslipidemia management are presented.
  • Novel theranostic tools for diagnosis are discussed.
  • Future treatment strategies involving advanced drug delivery systems are analyzed.

Conclusions:

  • Dyslipidemia management requires a combination of lifestyle modifications and appropriate pharmacotherapy.
  • The review provides current knowledge for healthcare professionals and researchers.
  • Advances in theranostics and drug delivery systems offer promising avenues for future clinical applications.

Keywords:
Dyslipidemiacardiovascular riskclinical trialsdiagnosisdrug carriersdrug targetstherapy

More Related Videos

Assessing Whole-Body Lipid-Handling Capacity in Mice07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.5K
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.9K

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
250
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.2K
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.2K
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
478
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
163
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.1K